Melanoma trials in Denmark

In Denmark 23 Also abroad 578

23 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
Dabrafenib and/or Trametinib Rollover Study
Where
Copenhagen Oe
Age
18 years to 100 years
People
100 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT03340506 · EU 2023-509318-13-00
Phase 1Taking people
Rituximab for Treatment of Checkpoint Inhibitor Induced Immune-related Adverse Events
Where
Herlev
Age
18 years and over
People
25
Run by
Inge Marie Svane
See details and how to joinNCT07694414 · EU 2026-525728-18-00
Phase 2/3Taking people
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Where
Aalborg, Aarhus N
Age
18 years and over
People
740 worldwide
Run by
Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00
Phase 1/2Taking people
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Where
Copenhagen, Herlev
Age
18 years and over
People
250 worldwide
Run by
BioInvent International AB
See details and how to joinNCT04752826 · EU 2023-509847-29-00
Phase 1Taking people
Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours
Where
Herlev
Age
18 years and over
People
106 worldwide
Run by
MonTa Biosciences ApS
See details and how to joinNCT04855435 · EU 2024-512294-26-00
Phase 3Taking people
Does peri-operative treatment with Tranexamic Acid reduce the early relapse rate for patients with melanoma; a randomised controlled trial
Where
Aalborg, Aarhus N, Copenhagen Oe, Herlev, Odense C, Roskilde, Vejle
Age
18 years and over
People
638
Run by
Aarhus University Hospital
See details and how to join2022-502633-26-00 · EU 2022-502633-26-00
Phase 2Taking people
Phase II randomized study evaluating a Pragmatic approach to Adoptive Cell Therapy (ACT) using an IL2 analog (ANV419/ANV600) vs High dose IL2 after Tumor Infiltrating Lymphocytes (TIL) Therapy in patients with melanoma, NSCLC and cervical cancer. The PragmaTIL
Where
Herlev
Age
18 years and over
People
24 worldwide
Run by
Vall D Hebron Institute Of Oncology
See details and how to join2023-506400-99-00 · EU 2023-506400-99-00
Phase 1Taking people
Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma
Where
Herlev
Age
18 years to 80 years
People
15
Run by
Inge Marie Svane
See details and how to joinNCT07501117 · EU 2025-524526-18-00
Phase 3Taking people
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Where
Aarhus N, Copenhagen Oe
Age
18 years and over
People
520 worldwide
Run by
IDEAYA Biosciences
See details and how to joinNCT07015190 · EU 2025-522387-32-00
Phase 3Taking people
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Where
Herlev
Age
18 years and over
People
680 worldwide
Run by
Immunocore Ltd
See details and how to joinNCT06112314
Phase 1Taking people
Neoadjuvant nivolumab and ipilimumab for patients with high-risk uveal melanoma
Where
Herlev
Age
18 years and over
People
15
Run by
Region Hovedstaden
See details and how to join2025-524953-15-00 · EU 2025-524953-15-00
No phaseEnrolling by invitation
The Role of Radiotherapy for the Management of Non-melanoma Skin Cancer in Denmark.
Where
Aarhus N
Age
18 years and over
People
2,900
Run by
University of Aarhus
See details and how to joinNCT07347392
No phaseTaking people
FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis
Where
Aarhus N
Age
18 years and over
People
20
Run by
University of Aarhus
See details and how to joinNCT06206707
Phase 2Taking people
[68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer
Where
Copenhagen Oe, Herlev
Age
18 years and over
People
20
Run by
Barbara Malene Fischer
See details and how to joinNCT07215182 · EU 2023-509549-11-00
Phase 1Taking people
To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma
Where
Herlev
Age
18 years to 75 years
People
10
Run by
Inge Marie Svane
See details and how to joinNCT06204991
Phase 3Taking people
Perioperative Treatment With Tranexamic Acid in Melanoma
Where
Aalborg, Aarhus, Copenhagen, Herlev, Vejle
Age
18 years to 80 years
People
1,204
Run by
University of Aarhus
See details and how to joinNCT05899465
Phase 1Taking people
T-cell Therapy with CRISPR PD1-edited Tumor Infiltrating Lymphocytes for Patients with Metastatic Melanoma
Where
Herlev
Age
18 years to 75 years
People
10
Run by
Inge Marie Svane
See details and how to joinNCT06783270 · EU 2023-510417-25-01
Phase 4Taking people
Electrochemotherapy versus standard radiotherapy for the treatment of basal cell carcinoma
Where
Herlev
Age
18 years and over
People
52
Run by
Region Hovedstaden
See details and how to join2024-519066-49-01 · EU 2024-519066-49-01
No phaseTaking people
The 4D PICTURE Project: Evaluating Metro Mapping As a Method to Support Shared Decision Making in Oncology
Where
Vejle
Age
18 years and over
People
500 worldwide
Run by
Leiden University Medical Center
See details and how to joinNCT06685562
Phase 1Taking people
ADP-TILIL7
Where
Herlev
Age
18 years and over
People
10
Run by
Herlev Hospital
See details and how to join2023-509665-20-00 · EU 2023-509665-20-00
Phase 2Taking people
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
Where
Aarhus, Copenhagen
Age
18 years and over
People
60 worldwide
Run by
IO Biotech
See details and how to joinNCT05280314
Phase 2Taking people
Melanoma Metastasized to the Brain and Steroids
Where
Aarhus N, Herlev, Odense C
Age
18 years and over
People
80
Run by
Inge Marie Svane
See details and how to joinNCT03563729 · EU 2024-516585-11-00
No phaseTaking people
The MELAcare Study: A New Method for Surveillance of Melanoma Patients
Where
Copenhagen
Age
18 years and over
People
378
Run by
Herlev and Gentofte Hospital
See details and how to joinNCT05253872